Chairman, Chief Science Officer, Co-Founder
Dr. Emanuel “Chip” Petricoin has been the Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a University Professor. Before this position, he served as Co-Director of the FDA-NCI Clinical Proteomics Program from 2001-2005, and a Senior Investigator within the Center for Biologics Evaluation and Research at the US Food and Drug Administration from 1993-2005.
Chip is a co-inventor on 40 filed and published patents and has authored over 300 peer-reviewed publications and invited reviews.
In 2012 Chip, along with a Virginia entrepreneur, founded Perthera. Perthera’s mission is to deploy next-generation technology for precision medicine to help cancer patients live longer healthier lives.
Chip received his Ph.D. in Microbiology from the University of Maryland.